Loading…
Lakewood-Amedex Biotherapeutics Inc Is A Clinical-Stage Biotechnology Company Developing A Novel Class Of Fast-Acting, Broad-Spectrum Antimicrobials - The Bisphosphocin Class - To Treat Infectious Diseases And Reduce The Threat Posed By Antibiotic-Resistant Bacterial Strains, Including Mrsa, Vre, And Others. The Company'S Main Product Is Nu-3, A Topically Delivered Antimicrobial Gel In Phase 2 Clinical Trials For The Treatment Of Mildly Infected Diabetic Foot Ulcers (Idfu). It Is Also Advancing A Portfolio Of Early-Stage Pipeline Compounds Developed From Its Bisphosphocin Platform Targeting Potential Disease Indications, Including Complicated Urinary Tract Infection (Cuti) And Pulmonary Infections.